Pancreatic stone protein (PSP) is an early (even before symptoms = pre-symptomatic diagnostic) biomarker of sepsis used in clinical practice, and our recent comprehensive review suggests that this biomarker can be used in hospitals to screen for nosocomial sepsis in high-risk patients and to help to diagnose sepsis [15]. This evidence concerns the gene REG1A and Sepsis.